Meiji infant formula sold in Taiwan will in future be exported from Japan as the company looks to capitalize on the "high quality" reputation held by Japanese goods.
Danish firm ZPD has won EU food approval for its chondroitin sulfate – a process that has been riddled by misapprehension and prejudice, the company says.
Quickly digestible milk proteins are better for reducing post-training muscle fatigue than casein and placebo, according to French researchers.
Indian cooperative Amul and Russian dairy Galactika have reportedly begun trade talks that if successful will see the export of Gujarati cheese and milk powder to Russia.
Nestlé has filed for a worldwide patent for a protein balancing product aimed at children aged 5-15.
DNA-based nutrition is set to grow in the UK as 10.3% of food consumption is motivated by a desire for personalised products, according to a Canadean survey.
Sports Nutrition 2014 explores the market and future opportunities for the sports nutrition industry, valued at more than $30bn globally, and you can join the action for free!
While the impact of the Russian embargo on whey and lactose exports is “limited”, the price of these ingredients will likely be affected, says 3A Business Consulting.
Dairy giant Arla's ingredients business is building a new whey processing facility for €38m to meet rising demand for the dairy fraction in infant, sports and clinical nutrition.
The European Commission (EC) will provide Private Storage Aid (PSA) for butter, skimmed milk powder (SMP), and certain cheeses to "alleviate" the impact of the Russian embargo on European Union...
A combination of demographic, social and economic factors is helping grow India’s baby food market, which is set to cross the US$250m mark in 2014, a new report has said. ...
Fonterra is prepared to pay NZ$615m (US$514m, €390m) for a 20% stake in Chinese baby food manufacturer Beingmate in its latest attempt to expand its presence in China’s lucrative infant formula...
Chinese retailer Suning Redbaby has reportedly begun offering an infant formula insurance policy that compensates customers in the event of a recall.
Fueled by the continuing success of its Global Performance Nutrition division, Irish dairy Glanbia recorded a double-digit increase in revenue for the first half of 2014.
Nestlé has recalled a batch of NAN brand infant formula in the Philippines after internal tests discovered products did not contain fatty acids specified on the label.
Will Danone silence the rumour mill by selling its medical nutrition business? Euromonitor health and wellness analyst Diana Cowland explains why the sale makes sense for the world's biggest yoghurt...
Arla Foods Ingredients (AFI) joint venture ArNoCo has begun production of whey protein concentrate (WPC) and lactose at its newly-constructed €50m (US$66.8m) plant in Germany.
Whey protein drinks may help people with type 2 diabetes control erratic glucose levels, according to research.
Sales slipped 6% and net profits 11% in Q2 for DSM’s human and animal nutrition arm as adverse currency movements, a slow US vitamins and omega-3 food supplements market and...
Labelling of infant formula sold in the Pakistani department of Punjab must now include the warning “mother’s milk is the best food for your baby and helps in preventing diarrhoea and...
The Joint FAO-WHO Expert Committee on Food Additives' (JECFA) backing of the use of red algae ingredient carrageenan in liquid infant formula will carry a "a great deal of weight"...
New Zealand’s Ministry for Primary Industries (MPI) has called on the food industry and interested parties to provide feedback on its proposed specifications for the manufacturing of infant formula.
Danone’s Nutricia division has been rapped again for exaggerated infant follow-on formula claims, this time in conjunction with UK retailing giant Tesco.
GEA has drafted in Chr. Hansen executive Christian Rolf Jacobsen to head up its new Powder Systems Europe business unit.
The European Food Safety Authority (EFSA) is calling for input from all stakeholders as it goes about revising its controversial gut and immune health claim guidance that dates back to 2011.